Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinbei Rukang Tablets for mammary gland hyperplasia (phlegm-blood stasis syndrome)
CTR20171019Phase 2Suspended
- Sponsor
- Guangxi Huahong Pharmaceutical
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Jinbei Rukang Pian in breast hyperplasia, sponsored by Guangxi Huahong Pharmaceutical. Started Oct 2017; status: suspended.
02
Drugs
Jinbei Rukang Pian
03
Conditions
breast hyperplasia
Beyond the preview
Go deeper on CTR20171019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171019.